GEN vs. TEAM, ADSK, NTES, SNOW, SQ, DDOG, NET, EA, RBLX, and HUBS
Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Atlassian (TEAM), Autodesk (ADSK), NetEase (NTES), Snowflake (SNOW), Block (SQ), Datadog (DDOG), Cloudflare (NET), Electronic Arts (EA), Roblox (RBLX), and HubSpot (HUBS). These companies are all part of the "prepackaged software" industry.
Genesis Healthcare vs.
Genesis Healthcare (NYSE:GEN) and Atlassian (NASDAQ:TEAM) are both large-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.
Genesis Healthcare has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Atlassian has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500.
In the previous week, Atlassian had 50 more articles in the media than Genesis Healthcare. MarketBeat recorded 51 mentions for Atlassian and 1 mentions for Genesis Healthcare. Atlassian's average media sentiment score of 0.53 beat Genesis Healthcare's score of 0.00 indicating that Atlassian is being referred to more favorably in the news media.
Genesis Healthcare currently has a consensus target price of $31.33, suggesting a potential upside of 13.86%. Atlassian has a consensus target price of $272.00, suggesting a potential upside of 7.78%. Given Genesis Healthcare's higher possible upside, equities research analysts plainly believe Genesis Healthcare is more favorable than Atlassian.
Genesis Healthcare has higher earnings, but lower revenue than Atlassian. Atlassian is trading at a lower price-to-earnings ratio than Genesis Healthcare, indicating that it is currently the more affordable of the two stocks.
Atlassian received 174 more outperform votes than Genesis Healthcare when rated by MarketBeat users. However, 65.52% of users gave Genesis Healthcare an outperform vote while only 64.84% of users gave Atlassian an outperform vote.
Genesis Healthcare has a net margin of 17.83% compared to Atlassian's net margin of -8.59%. Genesis Healthcare's return on equity of 155.48% beat Atlassian's return on equity.
82.1% of Genesis Healthcare shares are held by institutional investors. Comparatively, 94.4% of Atlassian shares are held by institutional investors. 3.3% of Genesis Healthcare shares are held by insiders. Comparatively, 38.5% of Atlassian shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Genesis Healthcare and Atlassian tied by winning 9 of the 18 factors compared between the two stocks.
Get Genesis Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genesis Healthcare Competitors List
Related Companies and Tools
This page (NYSE:GEN) was last updated on 1/20/2025 by MarketBeat.com Staff
Free GEN Stock Alerts